APAC Medical Image Analysis Software Market

APAC Medical Image Analysis Software Market Size (2023 to 2028)

The size of the Medical Image Analysis Software Market in the Asia Pacific was worth USD 0.74 billion in 2023. This value is estimated to be growing at a CAGR of 8.31%, to reach USD 1.10 billion by 2028. APAC market is expected to be one of the most lucrative markets and is considered to grow at a fastest rate during the forecast period due to the investments from both the public and private sector organizations and rapid growth in the aging population.

Factors such as developments in the healthcare infrastructure, technological advancements, Y-O-Y growth in the incidence of chronic diseases are primarily accelerating the market growth. Countries such as India and China had a large population suffering with diseases such as CVS and diabetes and this factor is expected to favour the market. Increasing awareness among the people regarding the early diagnosis of chronic diseases and betting financial conditions of the population in the Asia Pacific countries are expected act as positive signals to the growth rate of the market.

Lack of awareness, data security concerns and the shortage of skilled workforce are impeding the market growth to a small extent.

This research report on the APAC Medical Image Analysis Software Market segmented and sub-segmented into the following categories:

• By Image Type: 2D Imaging, 3D Imaging and 4D Imaging   
• By Imaging Technology: X-Ray, Computed Tomography, Positron Emission Tomography, Single Photon Emission Computed Tomography, Magnetic Resonance Imaging, Ultrasound and Radiographic Imaging
• By Application: Cardiovascular, Neurology, Dental, Urology, Orthopaedic, Oncology, Obstetrics and Gynaecology and Mammography
• By End-User: Hospitals, Research Centres and Diagnostic Centres
• By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC       

Regionally, the Asia Pacific is one of the most lucrative markets for the growth of medical image analysis software market and is projected to grow the highest during the forecast period. Factors such as growing demographics and emerging economies in countries such as India and China are anticipated to lead the growth of the market in this region.

China is leading the medical image analysis software with highest share in the market. Growing healthcare expenses and discretionary expenses is propelling the market growth in the APAC region. Increasing awareness relevant to the advantages associated with these systems is one of the factors adding fuel to the market. India is one of the countries of this region contributing to the majority of the share together with China. Growing demand for diagnostic imaging software in medical fields like dental, orthopedic, urology, neurology and oncology are to surge the market growth of the region. Increasing demand for medical imaging, which serves diagnosis of different diseases like cancer, cardiovascular, neurology and gynecological disorders and procedures like CT, MRI, ultrasound, PET and SPECT which has got various advantages like less need for surgery, less hospital admissions and reduce hospital stay which accelerates the market growth during the period.

Key market participants in the APAC Medical Image Analysis Software Market are Agfa HealthCare, Medviso AB, Aquilab, Bruker Corporation, Carestream Health Inc., Esaote S.p.A, GE Healthcare, Spacelabs Healthcare, Merge Healthcare Inc., Xinapse Systems Ltd., MIM Software Inc., Philips Healthcare, Claron Technologies, Siemens Healthcare and Toshiba Medical Systems Corporation.